Prolonged exposure to denicotinized cigarettes with or without transdermal nicotine

Drug and Alcohol Dependence

Volumn 104, Issue 1-2, 2009, Pages 23-33

  Donny, Eric C ^a   Jones, Melissa ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CHES   (United States)

Author keywords

Addiction; Conditioning; Dependence; Nicotine replacement therapy; Smoking; Treatment

Indexed keywords

COTININE; NICOTINE; NICOTINE PATCH; PLACEBO;

ADULT; AGED; ARTICLE; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; FEMALE; HABITUATION; HUMAN; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALE; MOTIVATION; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PROFILE OF MOOD STATES; RANDOMIZED CONTROLLED TRIAL; REINFORCEMENT; SMOKING CESSATION; SMOKING HABIT; TOBACCO DEPENDENCE; TRANSDERMAL PATCH; WITHDRAWAL SYNDROME;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; AFFECT; AGED; CARBON MONOXIDE; DOUBLE-BLIND METHOD; EXTINCTION, PSYCHOLOGICAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NICOTINE; NICOTINIC AGONISTS; PATIENT COMPLIANCE; QUESTIONNAIRES; REINFORCEMENT (PSYCHOLOGY); SELF ADMINISTRATION; SMOKING; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME; YOUNG ADULT;

EID: 67651122921     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2009.01.021     Document Type: Article

References (52)

1. Balfour D.J. The neurobiology of tobacco dependence: a preclinical perspective on the role of the dopamine projections to the nucleus accumbens. Nicotine Tob. Res. 6 (2004) 899-912 (corrected)
2. Balleine B.W., and Ostlund S.B. Still at the choice-point: action selection and initiation in instrumental conditioning. Ann. N.Y. Acad. Sci. 1104 (2007) 147-171
3. Becker K.M., Rose J.E., and Albino A.P. A randomized trial of nicotine replacement therapy in combination with reduced-nicotine cigarettes for smoking cessation. Nicotine Tob. Res. 10 (2008) 1139-1148
4. Bouton M.E. Context and behavioral processes in extinction. Learn Mem. 11 (2004) 485-494
5. Brody A.L., Mandelkern M.A., Costello M.R., Abrams A.L., Scheibal D., Farahi J., London E.D., Olmstead R.E., Rose J.E., and Mukhin A.G. Brain nicotinic acetylcholine receptor occupancy: effect of smoking a denicotinized cigarette. Int. J. Neuropsychopharmacol. 12 (2008) 305-316
6. Brody A.L., Mandelkern M.A., London E.D., Olmstead R.E., Farahi J., Scheibal D., Jou J., Allen V., Tiongson E., Chefer S.I., Koren A.O., and Mukhin A.G. Cigarette smoking saturates brain alpha 4 beta 2 nicotinic acetylcholine receptors. Arch. Gen. Psychiatry 63 (2006) 907-915
7. Brody A.L., Mandelkern M.A., Olmstead R.E., Allen-Martinez Z., Scheibal D., Abrams A.L., Costello M.R., Farahi J., Saxena S., Monterosso J., and London E.D. Ventral striatal dopamine release in response to smoking a regular vs a denicotinized cigarette. Neuropsychopharmacology 34 (2008) 282-289
8. Buchhalter A.R., Acosta M.C., Evans S.E., Breland A.B., and Eissenberg T. Tobacco abstinence symptom suppression: the role played by the smoking-related stimuli that are delivered by denicotinized cigarettes. Addiction (Abingdon, England) 100 (2005) 550-559
9. Chaudhri N., Caggiula A.R., Donny E.C., Palmatier M.I., Liu X., and Sved A.F. Complex interactions between nicotine and nonpharmacological stimuli reveal multiple roles for nicotine in reinforcement. Psychopharmacology 184 (2006) 353-366
10. Conklin C.A., and Tiffany S.T. Applying extinction research and theory to cue-exposure addiction treatments. Addiction (Abingdon, England) 97 (2002) 155-167
11. Dawkins L., Acaster S., and Powell J.H. The effects of smoking and abstinence on experience of happiness and sadness in response to positively valenced, negatively valenced, and neutral film clips. Addict. Behav. 32 (2007) 425-431
12. Dawkins L., Powell J.H., West R., Powell J., and Pickering A. A double-blind placebo controlled experimental study of nicotine: I. Effects on incentive motivation. Psychopharmacology 189 (2006) 355-367
13. Di Chiara G. Role of dopamine in the behavioural actions of nicotine related to addiction. Eur. J. Pharmacol. 393 (2000) 295-314
14. Donny E.C., Chaudhri N., Caggiula A.R., Evans-Martin F.F., Booth S., Gharib M.A., Clements L.A., and Sved A.F. Operant responding for a visual reinforcer in rats is enhanced by noncontingent nicotine: implications for nicotine self-administration and reinforcement. Psychopharmacology 169 (2003) 68-76
15. Donny E.C., Houtsmuller E., and Stitzer M.L. Smoking in the absence of nicotine: behavioral, subjective and physiological effects over 11 days. Addiction (Abingdon, England) 102 (2007) 324-334
16. Everitt B.J., Dickinson A., and Robbins T.W. The neuropsychological basis of addictive behaviour. Brain Res. Brain Res. Rev. 36 (2001) 129-138
17. Fagerstrom K.O. Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict. Behav. 3 (1978) 235-241
18. Fant R.V., Henningfield J.E., Shiffman S., Strahs K.R., and Reitberg D.P. A pharmacokinetic crossover study to compare the absorption characteristics of three transdermal nicotine patches. Pharmacol. Biochem. Behav. 67 (2000) 479-482
19. Faure A., Haberland U., Conde F., and El Massioui N. Lesion to the nigrostriatal dopamine system disrupts stimulus-response habit formation. J. Neurosci. 25 (2005) 2771-2780
20. Goldberg S.R., Spealman R.D., and Goldberg D.M. Persistent behavior at high rates maintained by intravenous self-administration of nicotine. Science (New York, NY) 214 (1981) 573-575
21. Hatsukami D.K. Nicotine addiction: past, present and future. Marian Fischman lecture given at the 2007 meeting of CPDD. Drug Alcohol Depend. 92 (2008) 312-316
22. Heatherton T.F., Kozlowski L.T., Frecker R.C., and Fagerstrom K.O. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br. J. Addict 86 (1991) 1119-1127
23. Henningfield J.E., Benowitz N.L., Slade J., Houston T.P., Davis R.M., and Deitchman S.D. Reducing the addictiveness of cigarettes. Council on Scientific Affairs, American Medical Association. Tobacco Control 7 (1998) 281-293
24. Henningfield J.E., and Goldberg S.R. Nicotine as a reinforcer in human subjects and laboratory animals. Pharmacol. Biochem. Behav. 19 (1983) 989-992
25. Hughes J.R., and Hatsukami D. Signs and symptoms of tobacco withdrawal. Arch. Gen. Psychiatry 43 (1986) 289-294
26. Ito R., Robbins T.W., and Everitt B.J. Differential control over cocaine-seeking behavior by nucleus accumbens core and shell. Nat. Neurosci. 7 (2004) 389-397
27. McNair D.M., Lorr M., and Droppleman L.F. Manual for the Profile of Mood States (1971), Educational and Industrial Testing Service, San Diego
28. Olausson P., Jentsch J.D., and Taylor J.R. Repeated nicotine exposure enhances reward-related learning in the rat. Neuropsychopharmacology 28 (2003) 1264-1271
29. Olausson P., Jentsch J.D., and Taylor J.R. Nicotine enhances responding with conditioned reinforcement. Psychopharmacology 171 (2004) 173-178
30. Palmatier M.I., Evans-Martin F.F., Hoffman A., Caggiula A.R., Chaudhri N., Donny E.C., Liu X., Booth S., Gharib M., Craven L., and Sved A.F. Dissociating the primary reinforcing and reinforcement-enhancing effects of nicotine using a rat self-administration paradigm with concurrently available drug and environmental reinforcers. Psychopharmacology 184 (2006) 391-400
31. Palmatier M.I., Liu X., Matteson G.L., Donny E.C., Caggiula A.R., and Sved A.F. Conditioned reinforcement in rats established with self-administered nicotine and enhanced by noncontingent nicotine. Psychopharmacology 195 (2007) 235-243
32. Perkins K.A., Gerlach D., Vender J., Grobe J., Meeker J., and Hutchison S. Sex differences in the subjective and reinforcing effects of visual and olfactory cigarette smoke stimuli. Nicotine Tob. Res. 3 (2001) 141-150
33. Perkins K.A., Grobe J.E., Caggiula A., Wilson A.S., and Stiller R.L. Acute reinforcing effects of low-dose nicotine nasal spray in humans. Pharmacol. Biochem. Behavior 56 (1997) 235-241
34. Pickworth W.B., Fant R.V., Nelson R.A., Rohrer M.S., and Henningfield J.E. Pharmacodynamic effects of new de-nicotinized cigarettes. Nicotine Tob. Res. 1 (1999) 357-364
35. Rezaishiraz H., Hyland A., Mahoney M.C., O'Connor R.J., and Cummings K.M. Treating smokers before the quit date: can nicotine patches and denicotinized cigarettes reduce cravings?. Nicotine Tob. Res. 9 (2007) 1139-1146
36. Rose J.E. Denicotinized cigarettes: a new tool to combat cigarette addiction?. Addiction (Abingdon, England) 102 (2007) 181-182
37. Rose J.E., and Behm F.M. Inhalation of vapor from black pepper extract reduces smoking withdrawal symptoms. Drug Alcohol Depend. 34 (1994) 225-229
38. Rose J.E., and Behm F.M. Extinguishing the rewarding value of smoke cues: pharmacological and behavioral treatments. Nicotine Tob. Res. 6 (2004) 523-532
39. Rose J.E., Behm F.M., Westman E.C., and Kukovich P. Precessation treatment with nicotine skin patch facilitates smoking cessation. Nicotine Tob. Res. 8 (2006) 89-101
40. Rose J.E., and Corrigall W.A. Nicotine self-administration in animals and humans: similarities and differences. Psychopharmacology 130 (1997) 28-40
41. Rose J.E., Tashkin D.P., Ertle A., Zinser M.C., and Lafer R. Sensory blockade of smoking satisfaction. Pharmacol. Biochem. Behav. 23 (1985) 289-293
42. Shahan T.A., Bickel W.K., Badger G.J., and Giordano L.A. Sensitivity of nicotine-containing and de-nicotinized cigarette consumption to alternative non-drug reinforcement: a behavioral economic analysis. Behav. Pharmacol. 12 (2001) 277-284
43. Shahan T.A., Bickel W.K., Madden G.J., and Badger G.J. Comparing the reinforcing efficacy of nicotine containing and de-nicotinized cigarettes: a behavioral economic analysis. Psychopharmacology 147 (1999) 210-216
44. Strasser A.A., Lerman C., Sanborn P.M., Pickworth W.B., and Feldman E.A. New lower nicotine cigarettes can produce compensatory smoking and increased carbon monoxide exposure. Drug Alcohol Depend. 86 (2007) 294-300
45. Tengs T.O., Ahmad S., Savage J.M., Moore R., and Gage E. The AMA proposal to mandate nicotine reduction in cigarettes: a simulation of the population health impacts. Prev. Med. 40 (2005) 170-180
46. Tiffany S.T. A cognitive model of drug urges and drug-use behavior: role of automatic and nonautomatic processes. Psychol. Rev. 97 (1990) 147-168
47. Tiffany S.T., and Drobes D.J. The development and initial validation of a questionnaire on smoking urges. Br. J. Addict. 86 (1991) 1467-1476
48. Waters A.J., Shiffman S., Sayette M.A., Paty J.A., Gwaltney C.J., and Balabanis M.H. Cue-provoked craving and nicotine replacement therapy in smoking cessation. J. Consult. Clin. Psychol. 72 (2004) 1136-1143
49. Watson D., Clark L.A., and Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J. Pers. Soc. Psychol. 54 (1988) 1063-1070
50. Westman E.C., Behm F.M., and Rose J.E. Dissociating the nicotine and airway sensory effects of smoking. Pharmacol. Biochem. Behav. 53 (1996) 309-315
51. White N.M. Addictive drugs as reinforcers: multiple partial actions on memory systems. Addiction (Abingdon, England) 91 (1996) 921-949 (discussion 951-965)
52. Yin H.H., Knowlton B.J., and Balleine B.W. Lesions of dorsolateral striatum preserve outcome expectancy but disrupt habit formation in instrumental learning. Eur. J. Neurosci. 19 (2004) 181-189